Navigation Links
Nobel Prize in Physiology or Medicine 2011: Jules Hoffmann
Date:10/4/2011

This year the prizes were awarded by the Nobel Committee for work that "has opened up new avenues for the development of prevention and therapy against infections, cancer and inflammatory diseases," explains the selection committee.

Born in Luxembourg in 1941, Jules Hoffmann went to university in Strasbourg, where he obtained a PhD in experimental biology. He joined CNRS in 1964, and then set up the CNRS laboratory on 'Immune response and development in insects', which he ran until 2006. This laboratory was part of the CNRS Institute of Molecular and Cellular Biology, of which he was also Director from 1994 to 2006. His many discoveries in this field have led to a new understanding of the defence mechanisms used by organisms, from the most primitive to the human body, against infectious agents.

The Nobel Committee explained how Jules Hoffmann, 70, and Bruce Beutler, 55, had "discovered receptor proteins that can recognize such microorganisms and activate innate immunity, the first step in the body's immune response".

For Andr Syrota, President of Aviesan, "This new Nobel Prize awarded just three years after the Nobel Prize received by Franoise Barr Sinoussi and Luc Montaignier demonstrates, if such proof were necessary, the excellence of French academic research in the life sciences." He sends his warmest congratulations to Jules Hoffmann and to CNRS and Strasbourg University.

President of the French Academy of Science in 2007 and 2008, Jules Hoffmann is also a member of the Academies of Science of the US, Germany and Russia. He is the recipient of many prestigious prizes such as the recent Rosenstiel Award for Immunity (2010), the Keio Medical Science Prize (2011), the Gairdner Award 2011 in medical science, and the Shaw Prize 2011 in Life Science and Medicine. He has just been awarded the 2011 CNRS Gold Medal.


'/>"/>

Contact: Juliette Hardy
presse@inserm.fr
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Page: 1

Related medicine news :

1. 2010 Chemistry Nobel laureate Ei-ichi Negishi leads C&EN webinar
2. Nobel laureates Brown, Goldstein to give inaugural Stadtman award lecture
3. Lifespan researcher wins Ig Nobel Prize
4. UT Southwestern scientist shares 2011 Nobel Prize in Physiology or Medicine
5. "New Cosmetic Surgery" Journalism Prize
6. ReNew Life Online Scavenger Hunt to Award Grand Prize Trip to Florida, Lunch with Brenda Watson
7. American Public Health Champion Receives 2010 Stockholm Water Prize
8. Prize4Life Inspires Award-winning ALS Film: Trapped
9. RAM founder to receive CWRUs Inamori Ethics Prize
10. Highest prize in public health -- the Frank A. Calderone Prize -- to Susan Baker, pioneer
11. Prize4Life Featured in Major Innovation/Prize National Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... The Nashville Business Journal recently ... in business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is ... 2015 Veterans Awards will recognize Nashville military veterans who, through their professional and ...
(Date:8/28/2015)... ... August 28, 2015 , ... SmartPractice Calendars afford ... with practice contact information and logos, Calendars stand alone as functional brand-building ... into seasonal mailings, thank you and welcome communications, and to complement statements and ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... Mendon, IL, ... of good music and good people, all for a good cause. In its second ... 2015, sponsored once more by Best Drug Rehabilitation. The “Mission” of “Music With A ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Louis W. ... technology innovation to transform quality and efficiency of healthcare delivery worldwide, announced the ... and aggregated before being publicly shared to document progress and inform policy in ...
(Date:8/28/2015)... ... August 28, 2015 , ... United Benefit Advisors ... TJS Insurance Group as its newest Partner Firm. Founded in 1924 and headquartered ... them focused on their goals. Within the past 10 years, TJS Insurance Group ...
Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 3
... , HORSHAM, Pa., Dec. 7 Teva Respiratory, ... ), today announced the publication of four articles in a ... of Allergy and Clinical Immunology (JACI), providing a comprehensive ... in the understanding and treatment of asthma. This represents the ...
... and treatment explain decrease , MONDAY, Dec. 7 (HealthDay ... have all continued to help cut the annual number ... a new report says. , The findings showed that ... significantly for both men and women and for most ...
... genetic approach to treating sickle cell disease is showing promising ... inactivating a gene they previously discovered to be important in ... healthy fetal form of hemoglobin in the mice, potentially compensating ... to "sickle" and obstruct blood flow. The study was ...
... ... ... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has begun shipping ... of Tamiflu will begin arriving in pharmacies nationwide and will continue to roll out to ...
... patients on Paxil became more extraverted and less ... (HealthDay News) -- Taking antidepressants may not only ... extraverted and less neurotic, new research suggests. , ... believed to help protect from depression, while neuroticism, ...
... ... today, Dr. David Hunt, a range of experts and healthcare leaders will focus on ... New Zealand healthcare industries will discuss lessons learned in developing functional health information exchanges ... ...
Cached Medicine News:Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:U.S. Cancer Cases, Deaths Continue to Drop 2Health News:U.S. Cancer Cases, Deaths Continue to Drop 3Health News:U.S. Cancer Cases, Deaths Continue to Drop 4Health News:New approach to sickle-cell disease shows promise in mice 2Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 2Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 3Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 4Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 5Health News:Antidepressants May Change Your Personality 2Health News:Antidepressants May Change Your Personality 3Health News:Antidepressants May Change Your Personality 4Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 2Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 3
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Insulin Aspart Market, ... Developed by Novo Nordisk, insulin aspart (under the ... for the treatment of diabetes. Compared with human ... analog, starts working fast and reports higher peak ...
(Date:8/28/2015)... , August 28, 2015 The ... in collaboration with one of the leading academics in the ... (current world record holder in life extension for model animals ... into biology of aging and age-related diseases, primarily, around the ... work has just been published as "Stability analysis of a ...
(Date:8/28/2015)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; TASE) ... leading OTC brands from GSK in an all cash ... clear demonstration of Perrigo,s unique ability to maximize brand ... 36 countries.  Perrigo Chairman, President and ... excited to complete this transaction, which clearly demonstrates our ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... NEW YORK, March 7, 2011 Reportlinker.com ... is available in its catalogue: ... Future Growth to be Driven by Improving ... http://www.reportlinker.com/p0409144/Aesthetic-Devices-Market-to-2017---Future-Growth-to-be-Driven-by-Improving-Treatment-Outcomes-and-Increase-in-Consumer-Confidence.html ...
... Therapeutics Inc. (TSX: NPC), today announced that their March ... LINK: www.retailinvestorconferences.com Click the red "register/ ... will be available 24/7 for 90 days. Investors may ... the next three weeks. About Allon ...
Cached Medicine Technology:Reportlinker Adds Aesthetic Devices Market to 2017 - Future Growth to be Driven by Improving Treatment Outcomes and Increase in Consumer Confidence 2Reportlinker Adds Aesthetic Devices Market to 2017 - Future Growth to be Driven by Improving Treatment Outcomes and Increase in Consumer Confidence 3Allon Therapeutics' CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com 2Allon Therapeutics' CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com 3
GelPort hand access laparoscopy combines the patient outcomes of minimally invasive surgery with the speed and precision of open surgery....
... series offers a range of standard, ... design delivers therapy to meet the ... results in commercial and clinical effectiveness ... in the SleepStyle 200 series is ...
... offers a range of standard, enhanced ... delivers therapy to meet the needs ... in commercial and clinical effectiveness and ... the SleepStyle 200 series is the ...
The S8 Escape is the economy model of ResMeds S8 series. The S8 Escape is ideal for patients who want the convenience and portability of the S8 models but do not require the added comfort features of...
Medicine Products: